IL2 and metabolic syndrome: The IL-2, IL-17A, and INF-γ were significantly greater in the MetS group at initial assessment, while the IL-10, IL-17A, TNF-α, and INF-γ were significantly greater in the MetS group at the annual assessment, with no changes observed following the one-year intervention.